Accrual and retention of diverse patients in psychosocial cancer clinical trials

被引:5
|
作者
Hanvey, Grace Ann [1 ]
Padron, Adaixa [1 ]
Kacel, Elizabeth L. [1 ]
Cartagena, Gabriel [1 ]
Bacharz, Kelsey C. [1 ]
McCrae, Christina S. [1 ]
Robinson, Michael E. [1 ]
Waxenberg, Lori B. [1 ]
Antoni, Michael H. [2 ]
Berry, Richard B. [3 ]
Schultz, Gregory S. [4 ]
Castagno, Jacqueline [4 ]
Pereira, Deidre B. [1 ]
机构
[1] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA
[2] Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA
[3] Univ Florida, Div Pulm Crit Care & Sleep Med, Gainesville, FL USA
[4] Univ Florida, Dept Obstet & Gynecol, Gainesville, FL 32611 USA
基金
美国国家卫生研究院;
关键词
Cancer; clinical trials; recruitment; retention; health disparities; SLEEP QUALITY INDEX; PSYCHOMETRIC PROPERTIES; PARTICIPATION; POPULATIONS; MINORITIES; INVENTORY; BARRIERS; HEALTH; PAIN;
D O I
10.1017/cts.2022.380
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Minority and older adult patients remain underrepresented in cancer clinical trials (CCTs). The current study sought to examine sociodemographic inequities in CCT interest, eligibility, enrollment, decline motivation, and attrition across two psychosocial CCTs for gynecologic, gastrointestinal, and thoracic cancers. Methods: Patients were approached for recruitment to one of two interventions: (1) a randomized control trial (RCT) examining effects of a cognitive-behavioral intervention targeting sleep, pain, mood, cytokines, and cortisol following surgery, or (2) a yoga intervention to determine its feasibility, acceptability, and effects on mitigating distress. Prospective RCT participants were queried about interest and screened for eligibility. All eligible patients across trials were offered enrollment. Patients who declined yoga intervention enrollment provided reasons for decline. Sociodemographic predictors of enrollment decisions and attrition were explored. Results: No sociodemographic differences in RCT interest were observed, and older patients were more likely to be ineligible. Eligible Hispanic patients across trials were significantly more likely to enroll than non-Hispanic patients. Sociodemographic factors predicted differences in decline motivation. In one trial, individuals originating from more urban areas were more likely to prematurely discontinue participation. Discussion: These results corroborate evidence of no significant differences in CCT interest across minority groups, with older adults less likely to fulfill eligibility criteria. While absolute Hispanic enrollment was modest, Hispanic patients were more likely to enroll relative to non-Hispanic patients. Additional sociodemographic trends were noted in decline motivation and geographical prediction of attrition. Further investigation is necessary to better understand inequities, barriers, and best recruitment practices for representative CCTs.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Breast and thyroid cancer: A multicenter study with Accrual to Clinical Trials Network
    Peckham, Merry
    Spencer, Horace J.
    Syed, Shorabuddin
    Armstrong, William B.
    Farwell, Donald Gregory
    Gal, Thomas J.
    Goldenberg, David
    Russell, Marika D.
    Solis, Roberto N.
    King, Deanne
    Stack, Brendan C.
    JOURNAL OF SURGICAL ONCOLOGY, 2022, 125 (08) : 1211 - 1217
  • [42] Hispanic accrual on randomized cancer clinical trials: A call to arms.
    Parra, Alberto
    Karnad, Anand B.
    Thompson, Ian Murchie
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [43] PATIENT ACCRUAL TO CLINICAL-TRIALS
    FRIEDMAN, MA
    CANCER TREATMENT REPORTS, 1987, 71 (06): : 557 - 558
  • [44] Revisiting Barriers to Clinical Trials Accrual
    Brundage, Michael D.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (03): : 219 - 220
  • [45] Do we want more cancer patients on clinical trials If so, what are the barriers to greater accrual
    Andrew J Vickers
    Trials, 9
  • [46] Do we want more cancer patients on clinical trials if so, what are the barriers to greater accrual
    Vickers, Andrew J.
    TRIALS, 2008, 9 (1)
  • [47] Addressing both community and institutional barriers increases accrual of minority patients in breast cancer clinical trials
    Trant, Amelia A.
    Walz, Lucas
    Allen, Whitney
    Verma, Hannah
    Le, Mindy
    DeJesus, Jose
    Hatzis, Christos
    Silber, Andrea
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [48] Enhancing accrual to clinical trials of minority patients with gynecologic malignancy.
    Lara, Olivia
    Pothuri, Bhavana
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] Willingness of older people with cancer to participate in cancer clinical trials is not a barrier to accrual.
    Chan, KK
    Siu, L
    Townsley, C
    Pond, G
    Marquez, C
    Straus, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 789S - 789S
  • [50] Web-based clinical trials information for patients: An accrual aid?
    Afrin, LB
    Gentry, JR
    Stuart, RK
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 1997, : 902 - 902